Advocacy Actions

2024-02-23 > Shanghai

Met with European Union Delegation to China IP Attache MISONNE Benoit

On 23rd February, the European Chamber Pharmaceutical Working Group Chair Raphael De Garnier met with the European Union Delegation to China IP Attache Benoit Missone to exchange the IP challenges facing the European pharmaceutical companies in China.

Read more
2024-02-21 > Shanghai

Met with China Society for Drug Regulation (CSDR)

On 21st February, European Chamber representative met with the China Society for Drug Regulation (CSDR) official in Beijing. It was a working-level meeting to discuss the new year's collaboration on the regulatory roundtable.

Read more
2024-02-09 > Beijing, Shanghai

Feedback Submitted to Ministry of Finance regarding the Notice of Public Consultation on Interim Measures for the Administration of Innovative Procurement Methods for Government Procurement Cooperation (Draft for Public Comment).

The European Chamber provided feedback to the Ministry of Finance on the Notice of Public Consultation on Interim Measures for the Administration of Innovative Procurement Methods. Key feedback points include addressing concerns about determining innovative products, recommending the inclusion of suppliers in the first purchase catalogue, adjusting the weighting of the price score, and extending research and development contract deadlines.

Read more
2024-02-09 > All chapters

Submission of feedback on 60GHz ahead of the EU-China ICT Dialogue

On 9th February 2024, European Chamber representatives provided written feedback to the EU Delegation on the 60GHz band.

Read more
2024-02-07 > Beijing, Shanghai

Financial Services Working Groups Meeting with Delegation of the European Union to China

On 7th February, representatives from the Financial Services Working Groups met with representatives from the Delegation of the European Union to China to discuss the upcoming high-level EU-China Working Group on Financial Regulation.

Read more
2024-02-05 > All chapters

Call for Comments on the Management Measures for Financial Leasing Companies (Draft for Comments)

On 5th February 2024, the Non-Banking Financial Institutions (NBFI) Working Group submitted comments to the National Financial Regulatory Administration (NFRA).

Read more
2024-01-31 > Shanghai

Meeting with Official from Shipping Division, Pudong Commission of Commerce

On 23 January, official from Shipping Department, Pudong Commission of Commerce visited European Chamber Shanghai chapter, for an industry investigation and short briefing of talent policy supports.

Read more
2024-01-31 > Beijing, Shanghai

Feedback Submitted to National Healthcare Security Administration on the Proposal for the Continuation of Centralised Volume-Based Procurement of Artificial Joints (Draft for Comments)

The Healthcare Equipment Working Group provided feedback to the National Healthcare Security Administration on the Proposal for the Continuation of Centralised Volume-Based Procurement of Artificial Joints (Draft for Comments).

Read more
2024-01-30 > Beijing, Shanghai

Healthcare Equipment Working Group Meeting

The HCE WG had a productive meeting discussing the medical device industry, focusing on its relation to other industries, multinational corporations' research and development in the Chinese market, and enhancing team capabilities. Plans for upcoming weeks and months were also discussed, including surveys, elections, and drafting a Position Paper in March. The Chamber will continue to collect feedback and promote collaboration.

Read more
2024-01-26 > Beijing, Shanghai

Meeting of the Consumable and Disposable Medical Device Advisory Committee (CDMD) GA Sub-group

The CDMD GA Sub-group, a committee for Consumable and Disposable Medical Devices, had a meeting on 26th January 2024. Two guest speakers, Kai Yang and Jun Liu from IQVIA, discussed trends and reforms in the medical devices industry. Yang talked about volume-based procurement (VBP) and the price catalogue for medical consumables in China, whilst Liu emphasised the importance of real-world evidence (RWE) in device approval decisions. Members expressed the need for a faster approval process and proposed a green channel for medical device products. The Chamber will further discuss and convey member opinions to relevant government departments.

Read more